Navigation Links
New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V
Date:5/31/2011

n (specific to solution for infusion), fall, and skin laceration. Refer to the European Summary of Product Characteristics for other adverse reactions and full prescribing information. Date of revision: 06 May 2011.

http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000863/WC500050338.pdf  (Accessed 19th May 2011)

About Epilepsy

Epilepsy is a chronic neurological disorder affecting approximately 40 million people worldwide and three million people in the US—making it as common as breast cancer.  Anyone can develop epilepsy; it occurs across all ages, races and genders. Uncontrolled seizures and medication side effects pose challenges to independent living, learning and employment, so the goal of epilepsy treatment is seizure freedom with minimal side effects.  More than 1 million patients in the US continue to have seizures despite initial therapy, and more than 800,000 patients in the US continue to have seizures despite treatment with two or more therapies. New medications and treatments give hope to those living with uncontrolled seizures.

Further Information
Andrea Levin, Senior Manager, Communications & PR, CNS, UCB, Inc.
T 770.970.8352
M 404.483.7329
Andrea.Levin@ucb.com

Laura Finley
Cooney/Waters Group
T 212.886.2258
LFinley@cooneywaters.com

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,000 people in about 40 count
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Reportlinker Adds Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
2. Reportlinker Adds Global Top 10 Pharmaceutical Companies: Industry, Financial and SWOT Analysis
3. Reportlinker Adds Triple Analysis: Colorectal Cancer, Lymphoma and Peptides
4. Reportlinker Adds Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer
5. Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies
6. Reportlinker Adds Triple Analysis: Colorectal Cancer, Lymphoma and Pancreatic Cancer
7. Reportlinker Adds United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017
8. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
9. Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides
10. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides
11. Reportlinker Adds Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... keynote address last month that industry is compelled to ... to gain the efficiencies—and develop the transformational innovations -- ... Barsoum,s comments were preceded by Doug Kohrs , ... OMTEC moderator, who stressed that industry must add "episode ...
(Date:7/30/2015)... FAIRFIELD, N.J. , July 30, 2015 /PRNewswire/ ... Ferrer, completed the second Phase III clinical study ... development for impetigo.  Medimetriks owns the exclusive U.S. ... The global trial, conducted at 44 centers with ... and pediatric patients aged 2 months and older ...
(Date:7/30/2015)... Calif. , July 30, 2015   ... to eliminate all preventable hospitalization, recently received confirmation ... its Remote Patient Intelligence (RPI) solution meets the ... FDA intends to exercise "Enforcement Discretion." ... not subject to further FDA regulatory requirements at ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3
(Date:7/30/2015)... ... July 30, 2015 , ... Dale Sky Jones, Executive Chancellor of ... the International Cannabis Professionals Expo held at the Caribe Royal All Suites Hotel and ... Professionals Expo is the largest medical cannabis expo in the country and this ...
(Date:7/30/2015)... ... 31, 2015 , ... The Venetian on Grace Bay in the Turks & Caicos Islands is ... Venetian will save 40% on their stay while enjoying some of the most beautiful ocean ... & Caicos, providing a chance to reconnect with loved ones and rediscover one's best self. ...
(Date:7/30/2015)... ... July 31, 2015 , ... Committed to helping the ... by asking community members to contribute to the College’s “My Brother’s Keeper Scholarship.” The ... young people stay on track. Providing the support they need to think more broadly ...
(Date:7/30/2015)... Sierra Madre, CA (PRWEB) , ... July 30, 2015 , ... ... wound care programs, the activity of recruiting patients becomes a serious challenge. Because of ... wound care program to patients within the local community. , The team at ...
(Date:7/30/2015)... ... July 30, 2015 , ... OSF Healthcare System has been ... Most Wired Survey conducted by Hospitals & Health Networks. This marks the fourth consecutive ... by The Sisters of the Third Order of St. Francis . , Health ...
Breaking Medicine News(10 mins):Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
... Cytori Therapeutics (NASDAQ: CYTX) announced today the ... European Journal of Surgical Oncology. , ... trial using autologous adipose-derived regenerative cell (ADRC)-enriched fat ... surgery. The majority of patients underwent radiation prior ...
... sudden hearing loss, a frightening condition that sends thousands in ... this month in the journal OtolaryngologyHead and Neck Surgery ... led by Robert J. Stachler, M.D., an otolaryngologist in the ... in Detroit. "In most cases, patients will have ...
... , MONDAY, March 19 (HealthDay News) -- The emergency room ... blackouts can be more than half a million dollars a ... new study found. The University of Wisconsin-Madison ... the 28 days before the start of the study, male ...
... of Granada researchers have developed a software tool that ... person has to suffer a heart disease. In addition, ... estimations, i.e. it helps estimating the risk that a ... The researchers employed a sample including 3 000 patients. ...
... March 17 (HealthDay News) -- People who follow seven ... die than those who follow few or none of ... 45,000 U.S. adults. However, the researchers also found ... recommended by the American Heart Association (AHA), which include: ...
... 17 (HealthDay News) -- Teens and young adults who binge ... be risking brain damage, an expert warns. Binge drinking, ... drinks by males and three drinks by females in a ... said Dr. Alicia Ann Kowalchuk, medical director of the InSight ...
Cached Medicine News:Health News:Cytori breast reconstruction cell therapy trial results published 2Health News:First national guideline for sudden hearing loss published 2Health News:Excessive Drinking Costs U.S. Colleges Millions Annually 2Health News:Scientists develop a software tool for estimating heart disease risk 2Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 2Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 3Health News:Spring Break Boozing May Put Young Brains at Risk 2
Minimal M9CA Broth...
An agent used for making solid microbiological media....
... of miniTHERM incubators is available, ensuring the ... for their specific requirements. miniTHERM incubators have ... and extremely space saving. Their size corresponds ... is possible to stack up to three ...
In microbiological laboratories and for in vitro fertilization, as well as in cancer research or tissue engineering, the Heraeus CO2 incubator BBD 6220 provides the best contamination protection and ...
Medicine Products: